{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T18:48:05Z","timestamp":1789325285102,"version":"build-2803163510"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012681","name":"Universit\u00e4tsklinikum K\u00f6ln","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012681","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Tuberculosis (TB) remains a leading cause of morbidity and mortality, with 1.3\u00a0million deaths in 2022. Extrapulmonary tuberculosis (EPTB) accounts for approximately 20% of all TB cases. We assessed the clinical presentation and challenges during the course of treatment in EPTB patients in a low-incidence setting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a prospective cohort study involving 44 EPTB patients at the University Hospital of Cologne, Germany. Clinical data were collected before and during treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The cohort comprised 44 patients originating from 21 countries. Two or more invasive procedures were required for microbiological confirmation in 59% (26\/44) of the cases. Sputum culture was positive in 18% (8\/44) of patients, with 63% (5\/8) showing no radiological signs of pulmonary involvement. The median therapy duration was ten months and increased with disease severity. Paradoxical reactions (PR) occurred in 31% (13\/42) of the patients. A previously published clinical scoring system assessing EPTB treatment responses showed a favorable treatment outcome in only 68% (21\/31) of the patients in this cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>EPTB exhibits highly variable disease severity and organ involvement. Treatment initiation is often delayed due to diagnostic challenges. Management is complicated by the frequent occurrence of PR, which can lead to treatment durations exceeding standard recommendations. Clinical scores for treatment response assessment may not be reliably applicable, highlighting the need for alternative biomarkers.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s15010-025-02500-4","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T05:38:05Z","timestamp":1741671485000},"page":"1809-1818","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Clinical heterogeneity and treatment outcomes of extrapulmonary tuberculosis in a low-incidence setting: insights from a prospective cohort study"],"prefix":"10.1007","volume":"53","author":[{"given":"Angela","family":"Klingm\u00fcller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Feldmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Rohr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"Helmhold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Junker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarete","family":"Scherer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg-Janne","family":"Vehreschild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Schmidt-Hellerau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ada","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Jantsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Simonis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic","family":"Rauschning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Funke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob J.","family":"Malin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena M.","family":"Biehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Schommers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"F\u00e4tkenheuer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Rybniker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,11]]},"reference":[{"key":"2500_CR1","unstructured":"Global Tuberculosis Report 2023. Geneva: World Health Organization; 2023. https:\/\/www.who.int\/teams\/global-tuberculosis-programme\/tb-reports\/global-tuberculosis-report-2023. Date last accessed: August 2 2024."},{"key":"2500_CR2","unstructured":"World Health Organization. WHO consolidated guidelines on tuberculosis: module 4: treatment: drug-susceptible tuberculosis treatment. https:\/\/www.who.int\/publications\/i\/item\/9789240048126. Date last updated: May 24 2022. Date last accessed: August 2 2024."},{"key":"2500_CR3","doi-asserted-by":"crossref","unstructured":"Sandgren A, Hollo Vvan der Werf MJ. Extrapulmonary tuberculosis in the European union and European economic area, 2002 to 2011. Euro Surveill. 2013;18(12).","DOI":"10.2807\/ese.18.12.20431-en"},{"key":"2500_CR4","unstructured":"World Health Organization and the European Centre for Disease Prevention and Control. Tuberculosis surveillance and monitoring in Europe 2024, 2022 data. https:\/\/www.ecdc.europa.eu\/en\/publications-data\/tuberculosis-surveillance-and-monitoring-europe-2024-2022-data. Date last updated: March 21 2024. Date last accessed: August 2 2024."},{"issue":"9","key":"2500_CR5","doi-asserted-by":"publisher","first-page":"e13471","DOI":"10.1016\/j.cmi.2020.12.006","volume":"27","author":"SE Hayward","year":"2021","unstructured":"Hayward SE, Rustage K, Nellums LB, van der Werf MJ, Noori T, Boccia D, et al. Extrapulmonary tuberculosis among migrants in Europe, 1995 to 2017. Clin Microbiol Infect. 2021;27(9):e13471\u20137. https:\/\/doi.org\/10.1016\/j.cmi.2020.12.006.","journal-title":"Clin Microbiol Infect"},{"key":"2500_CR6","unstructured":"Robert Koch Institut, Epidemiologisches, Bulletin. Welttuberkulosetag 2022. https:\/\/www.rki.de\/DE\/Content\/Infekt\/EpidBull\/Archiv\/2022\/Ausgaben\/11_22.html. Date last updated: March 17 2022. Date last accessed: August 2 2024."},{"issue":"10","key":"2500_CR7","doi-asserted-by":"publisher","first-page":"e352","DOI":"10.1016\/S1473-3099(19)30162-8","volume":"19","author":"I Suarez","year":"2019","unstructured":"Suarez I, Maria Funger S, Jung N, Lehmann C, Reimer RP, Mehrkens D, et al. Severe disseminated tuberculosis in HIV-negative refugees. Lancet Infect Dis. 2019;19(10):e352\u20139. https:\/\/doi.org\/10.1016\/S1473-3099(19)30162-8.","journal-title":"Lancet Infect Dis"},{"key":"2500_CR8","unstructured":"Robert-Koch-Institut. Bericht zur Epidemiologie der Tuberkulose in Deutschland f\u00fcr 2022. https:\/\/www.rki.de\/DE\/Content\/InfAZ\/T\/Tuberkulose\/Archiv_Berichte_TB_in_Dtl_tab.html#:~:text=RKI%20%2DBericht%20zur%20Epidemiologie%20der,Neuerkrankungen%20pro%20100.000%20Einwohner%20entspricht. Date last updated: December 20 2023. Date last accessed: August 2 2024."},{"key":"2500_CR9","unstructured":"Robert-Koch-Institut. Epidemiologisches Bulletin: Tuberkulose bei Patientinnen und Patienten mit Geburtsland Ukraine in Deutschland im Jahr 2022. https:\/\/www.rki.de\/DE\/Content\/Infekt\/EpidBull\/Archiv\/2023\/11\/Art_02.html#:~:text=Die%20im%20Epidemiologischen%20Bulletin%2011,um%20Betroffenen%20die%20bestm%C3%B6gliche%20Tuber%2D. Date last updated: March 16 2023. Date last accessed: August 2 2024."},{"issue":"1","key":"2500_CR10","doi-asserted-by":"publisher","first-page":"e0190207","DOI":"10.1371\/journal.pone.0190207","volume":"13","author":"BE Feleke","year":"2018","unstructured":"Feleke BE, Alene GD, Feleke TE, Motebaynore YBiadglegne F. Clinical response of tuberculosis patients, a prospective cohort study. PLoS ONE. 2018;13(1):e0190207. https:\/\/doi.org\/10.1371\/journal.pone.0190207.","journal-title":"PLoS ONE"},{"key":"2500_CR11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s40545-020-00227-1","volume":"13","author":"M Atif","year":"2020","unstructured":"Atif M, Fatima R, Ahmad NBabar ZU. Treatment outcomes of extrapulmonary tuberculosis in Bahawalpur, Pakistan; a record review. J Pharm Policy Pract. 2020;13:35. https:\/\/doi.org\/10.1186\/s40545-020-00227-1.","journal-title":"J Pharm Policy Pract"},{"key":"2500_CR12","doi-asserted-by":"publisher","unstructured":"J\u00f8rstad MD, Dyrhol-Riise AM, A\u00dfmus J, Marijani M, Sviland LMustafa T. Evaluation of treatment response in extrapulmonary tuberculosis in a low-resource setting. BMC Infect Dis. 2019;19(1). https:\/\/doi.org\/10.1186\/s12879-019-4034-z.","DOI":"10.1186\/s12879-019-4034-z"},{"key":"2500_CR13","unstructured":"Bradby H, Humphris R, Newall DPhillimore J. Public health aspects of migrant health: A review of the evidence on health status for refugees and asylum seekers in the European region. Copenhagen; 2015."},{"key":"2500_CR14","unstructured":"World Bank. Country classification - World Bank Country and Lending Groups. https:\/\/datahelpdesk.worldbank.org\/knowledgebase\/articles\/906519-world-bank-country-and-lending-groups. Date last accessed: August 2 2024."},{"issue":"2","key":"2500_CR15","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s15010-012-0376-9","volume":"41","author":"G Geri","year":"2013","unstructured":"Geri G, Passeron A, Heym B, Arlet JB, Pouchot J, Capron L, et al. Paradoxical reactions during treatment of tuberculosis with extrapulmonary manifestations in HIV-negative patients. Infection. 2013;41(2):537\u201343. https:\/\/doi.org\/10.1007\/s15010-012-0376-9.","journal-title":"Infection"},{"issue":"2","key":"2500_CR16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.4046\/trd.2015.78.2.47","volume":"78","author":"JY Lee","year":"2015","unstructured":"Lee JY. Diagnosis and treatment of extrapulmonary tuberculosis. Tuberc Respir Dis (Seoul). 2015;78(2):47\u201355. https:\/\/doi.org\/10.4046\/trd.2015.78.2.47.","journal-title":"Tuberc Respir Dis (Seoul)"},{"issue":"12","key":"2500_CR17","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1093\/cid\/ciu186","volume":"58","author":"FM Marx","year":"2014","unstructured":"Marx FM, Dunbar R, Enarson DA, Williams BG, Warren RM, van der Spuy GD, et al. The Temporal dynamics of relapse and reinfection tuberculosis after successful treatment: a retrospective cohort study. Clin Infect Dis. 2014;58(12):1676\u201383. https:\/\/doi.org\/10.1093\/cid\/ciu186.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"2500_CR18","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s15010-022-01921-9","volume":"51","author":"N Wetzstein","year":"2023","unstructured":"Wetzstein N, Drummer AP, Bockey A, Herrmann E, Kupper-Tetzel CP, Graf C, et al. Occurrence of extrapulmonary tuberculosis is associated with geographical origin: Spatial characteristics of the Frankfurt TB cohort 2013\u20132018. Infection. 2023;51(3):679\u201387. https:\/\/doi.org\/10.1007\/s15010-022-01921-9.","journal-title":"Infection"},{"issue":"6","key":"2500_CR19","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1159\/000499052","volume":"97","author":"VD Mathiasen","year":"2019","unstructured":"Mathiasen VD, Hansen AK, Eiset AH, Lillebaek TWejse C. Delays in the diagnosis and treatment of tuberculous lymphadenitis in Low-Incidence countries: A systematic review. Respiration. 2019;97(6):576\u201384. https:\/\/doi.org\/10.1159\/000499052.","journal-title":"Respiration"},{"issue":"6","key":"2500_CR20","doi-asserted-by":"publisher","first-page":"e004818","DOI":"10.1136\/bmjopen-2014-004818","volume":"4","author":"J Virenfeldt","year":"2014","unstructured":"Virenfeldt J, Rudolf F, Camara C, Furtado A, Gomes V, Aaby P, et al. Treatment delay affects clinical severity of tuberculosis: a longitudinal cohort study. BMJ Open. 2014;4(6):e004818. https:\/\/doi.org\/10.1136\/bmjopen-2014-004818.","journal-title":"BMJ Open"},{"key":"2500_CR21","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/1471-2334-8-72","volume":"8","author":"G Meintjes","year":"2008","unstructured":"Meintjes G, Schoeman H, Morroni C, Wilson DMaartens G. Patient and provider delay in tuberculosis suspects from communities with a high HIV prevalence in South Africa: a cross-sectional study. BMC Infect Dis. 2008;8:72. https:\/\/doi.org\/10.1186\/1471-2334-8-72.","journal-title":"BMC Infect Dis"},{"key":"2500_CR22","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ijid.2016.10.025","volume":"54","author":"H Chahed","year":"2017","unstructured":"Chahed H, Hachicha H, Berriche A, Abdelmalek R, Mediouni A, Kilani B, et al. Paradoxical reaction associated with cervical lymph node tuberculosis: predictive factors and therapeutic management. Int J Infect Dis. 2017;54:4\u20137. https:\/\/doi.org\/10.1016\/j.ijid.2016.10.025.","journal-title":"Int J Infect Dis"},{"issue":"1","key":"2500_CR23","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1186\/s12879-016-1816-4","volume":"16","author":"CS Brown","year":"2016","unstructured":"Brown CS, Smith CJ, Breen RA, Ormerod LP, Mittal R, Fisk M, et al. Determinants of treatment-related Paradoxical reactions during anti-tuberculosis therapy: a case control study. BMC Infect Dis. 2016;16(1):479. https:\/\/doi.org\/10.1186\/s12879-016-1816-4.","journal-title":"BMC Infect Dis"},{"key":"2500_CR24","doi-asserted-by":"publisher","first-page":"8451","DOI":"10.1038\/ncomms9451","volume":"6","author":"RPJ Lai","year":"2015","unstructured":"Lai RPJ, Meintjes G, Wilkinson KA, Graham CM, Marais S, Van der Plas H, et al. HIV-tuberculosis-associated immune reconstitution inflammatory syndrome is characterized by Toll-like receptor and inflammasome signalling. Nat Commun. 2015;6:8451. https:\/\/doi.org\/10.1038\/ncomms9451.","journal-title":"Nat Commun"},{"issue":"6","key":"2500_CR25","doi-asserted-by":"publisher","first-page":"677","DOI":"10.5588\/ijtld.16.0927","volume":"21","author":"DA Barr","year":"2017","unstructured":"Barr DA, Coussens AK, Irvine S, Ritchie ND, Herbert K, Choo-Kang B, et al. Paradoxical upgrading reaction in extra-pulmonary tuberculosis: association with vitamin D therapy. Int J Tuberc Lung Dis. 2017;21(6):677\u201383. https:\/\/doi.org\/10.5588\/ijtld.16.0927.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"4","key":"2500_CR26","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.ijtb.2020.07.021","volume":"67","author":"DK Rai","year":"2020","unstructured":"Rai DK, Kumar RAhmad S. Clinical characteristics and treatment outcome in tubercular lymphadenitis patients- A prospective observational study. Indian J Tuberc. 2020;67(4):528\u201333. https:\/\/doi.org\/10.1016\/j.ijtb.2020.07.021.","journal-title":"Indian J Tuberc"},{"issue":"47","key":"2500_CR27","doi-asserted-by":"publisher","first-page":"e348","DOI":"10.3346\/jkms.2023.38.e348","volume":"38","author":"J Choe","year":"2023","unstructured":"Choe J, Han A, Shin SH, Lee K, Um SW, Kim H, et al. Clinical course of patients with mediastinal lymph node tuberculosis and risk factors for Paradoxical responses. J Korean Med Sci. 2023;38(47):e348. https:\/\/doi.org\/10.3346\/jkms.2023.38.e348.","journal-title":"J Korean Med Sci"},{"issue":"4","key":"2500_CR28","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s15010-020-01430-7","volume":"48","author":"MM Done","year":"2020","unstructured":"Done MM, Akkerman OW, Al-Kailany W, de Lange WCM, de Jonge G, Kleinnijenhuis J, et al. Corticosteroid therapy for the management of Paradoxical inflammatory reaction in patients with pulmonary tuberculosis. Infection. 2020;48(4):641\u20135. https:\/\/doi.org\/10.1007\/s15010-020-01430-7.","journal-title":"Infection"},{"issue":"1","key":"2500_CR29","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jinf.2009.05.006","volume":"59","author":"OH Cho","year":"2009","unstructured":"Cho OH, Park KH, Kim T, Song EH, Jang EY, Lee EJ, et al. Paradoxical responses in non-HIV-infected patients with peripheral lymph node tuberculosis. J Infect. 2009;59(1):56\u201361. https:\/\/doi.org\/10.1016\/j.jinf.2009.05.006.","journal-title":"J Infect"},{"issue":"4","key":"2500_CR30","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/S0749-0690(18)30438-5","volume":"8","author":"ME Ben-Yehuda AWeksler","year":"1992","unstructured":"Ben-Yehuda AWeksler ME. Host resistance and the immune system. Clin Geriatr Med. 1992;8(4):701\u201311.","journal-title":"Clin Geriatr Med"},{"issue":"4","key":"2500_CR31","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s15010-008-7199-8","volume":"36","author":"CS Wang","year":"2008","unstructured":"Wang CS, Chen HC, Yang CJ, Wang WY, Chong IW, Hwang JJ, et al. The impact of age on the demographic, clinical, radiographic characteristics and treatment outcomes of pulmonary tuberculosis patients in Taiwan. Infection. 2008;36(4):335\u201340. https:\/\/doi.org\/10.1007\/s15010-008-7199-8.","journal-title":"Infection"},{"issue":"7","key":"2500_CR32","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1093\/cid\/ciw376","volume":"63","author":"P Nahid","year":"2016","unstructured":"Nahid P, Dorman SE, Alipanah N, Barry PM, Brozek JL, Cattamanchi A, et al. Official American thoracic society\/centers for disease control and prevention\/infectious diseases society of America clinical practice guidelines: treatment of Drug-Susceptible tuberculosis. Clin Infect Dis. 2016;63(7):e147\u201395. https:\/\/doi.org\/10.1093\/cid\/ciw376.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"2500_CR33","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1513\/AnnalsATS.201401-004AR","volume":"11","author":"PC Hopewell","year":"2014","unstructured":"Hopewell PC, Fair ELUplekar M. Updating the international standards for tuberculosis care. Entering the era of molecular diagnostics. Ann Am Thorac Soc. 2014;11(3):277\u201385. https:\/\/doi.org\/10.1513\/AnnalsATS.201401-004AR.","journal-title":"Ann Am Thorac Soc"},{"key":"2500_CR34","doi-asserted-by":"publisher","first-page":"1177045","DOI":"10.3389\/fmed.2023.1177045","volume":"10","author":"T Yu","year":"2023","unstructured":"Yu T, Zhang L, Xu J, Meng J, Yu XZhang Y. The value of multimodal ultrasonography in evaluating therapeutic response of cervical tuberculous lymphadenitis to anti-tuberculosis drugs. Front Med (Lausanne). 2023;10:1177045. https:\/\/doi.org\/10.3389\/fmed.2023.1177045.","journal-title":"Front Med (Lausanne)"},{"key":"2500_CR35","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ijid.2014.12.007","volume":"32","author":"E Skoura","year":"2015","unstructured":"Skoura E, Zumla ABomanji J. Imaging in tuberculosis. Int J Infect Dis. 2015;32:87\u201393. https:\/\/doi.org\/10.1016\/j.ijid.2014.12.007.","journal-title":"Int J Infect Dis"},{"issue":"4","key":"2500_CR36","doi-asserted-by":"publisher","first-page":"e18474","DOI":"10.1371\/journal.pone.0018474","volume":"6","author":"A Bernabe-Ortiz","year":"2011","unstructured":"Bernabe-Ortiz A, Carcamo CP, Sanchez JFRios J. Weight variation over time and its association with tuberculosis treatment outcome: a longitudinal analysis. PLoS ONE. 2011;6(4):e18474. https:\/\/doi.org\/10.1371\/journal.pone.0018474.","journal-title":"PLoS ONE"},{"issue":"1","key":"2500_CR37","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41598-023-51026-y","volume":"14","author":"F Wagnew","year":"2024","unstructured":"Wagnew F, Alene KA, Kelly MGray D. Impacts of body weight change on treatment outcomes in patients with multidrug-resistant tuberculosis. Northwest Ethiopia Sci Rep. 2024;14(1):508. https:\/\/doi.org\/10.1038\/s41598-023-51026-y.","journal-title":"Northwest Ethiopia Sci Rep"},{"key":"2500_CR38","doi-asserted-by":"publisher","unstructured":"Guillouzouic A, Andrejak C, Peuchant O, Hery-Arnaud G, Hamdad F, Lanotte P, et al. Treatment of bone and joint tuberculosis in France: A multicentre retrospective study. J Clin Med. 2020;9(8). https:\/\/doi.org\/10.3390\/jcm9082529.","DOI":"10.3390\/jcm9082529"},{"issue":"4","key":"2500_CR39","doi-asserted-by":"publisher","first-page":"441","DOI":"10.4103\/aian.AIAN_141_20","volume":"23","author":"DGV Garg","year":"2020","unstructured":"Garg DGV. Spinal tuberculosis treatment: an enduring bone of contention. Ann Indian Acad Neurol. 2020;23(4):441\u20138. https:\/\/doi.org\/10.4103\/aian.AIAN_141_20.","journal-title":"Ann Indian Acad Neurol"},{"issue":"1","key":"2500_CR40","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s43162-023-00225-0","volume":"35","author":"N Naser","year":"2023","unstructured":"Naser N, Abdulla HKadhem H. Extra-long treatment of MDR-TB osteomyelitis of humerus due to neurotoxicity from the 2nd-line drugs: a case report. Egypt J Intern Med. 2023;35(1):41. https:\/\/doi.org\/10.1186\/s43162-023-00225-0.","journal-title":"Egypt J Intern Med"},{"key":"2500_CR41","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ebiom.2017.11.002","volume":"26","author":"S Babu","year":"2017","unstructured":"Babu S. Biomarkers for treatment monitoring in tuberculosis: A new hope. EBioMedicine. 2017;26:13\u20134. https:\/\/doi.org\/10.1016\/j.ebiom.2017.11.002.","journal-title":"EBioMedicine"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-025-02500-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-025-02500-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-025-02500-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T13:41:27Z","timestamp":1758721287000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s15010-025-02500-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,11]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["2500"],"URL":"https:\/\/doi.org\/10.1007\/s15010-025-02500-4","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,11]]},"assertion":[{"value":"6 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study received approval from the Ethics Committee of the University of Cologne (18\u2013079).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from each study participant.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}